What one share of Allurion Technologies holds
Our company is pioneering metabolically healthy weight loss by creating a best-in-class weight loss platform to treat the estimated two billion people globally who are overweight.
Allurion Technologies’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-03-31; the balance sheet is as of 2026-03-31.
| Sales | $1.30 |
|---|---|
| Profit | −$3.45 |
| Cash and investments | $0.34 |
| Debt | $2.90 |
| Book value | −$5.20 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | $59.63 | −$37.75 | $1.44 | −$45.07 | — | −$29.83 |
| 2023 | $37.57 | −$59.38 | $1.13 | −$46.08 | — | −$37.38 |
| 2024 | $14.29 | −$3.20 | $0.27 | −$19.10 | — | −$28.77 |
| 2025 | $2.02 | −$3.81 | — | — | — | −$6.29 |
Common questions about Allurion Technologies
How much does one share of Allurion Technologies earn?
Over the last 12 months, Allurion Technologies lost $3.45 for each share on $1.30 of sales.
Does Allurion Technologies pay a dividend?
Allurion Technologies didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Allurion Technologies’s book value per share?
Allurion Technologies’s book value is negative (−$5.20 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of March 31, 2026.
How much cash and debt does each share of Allurion Technologies have?
Each share of Allurion Technologies has $0.34 of cash and investments and $2.90 of debt, as of March 31, 2026.
Has Allurion Technologies bought back shares?
Allurion Technologies’s share count rose about 601% from 2022 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.